WAM
UTHR icon

Weiss Asset Management’s United Therapeutics UTHR Stock Holding History

Weiss Asset Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.24M Buy
+2,281
New +$1.28M 0.01% 399
2026
Q1 		– Sell
-2,880
Closed -$1.4M – 799
2025
Q4 		$1.4M Buy
+2,880
New +$1.34M 0.02% 360
2024
Q1 		– Sell
-2,634
Closed -$579K – 499
2023
Q4 		$579K Buy
+2,634
New +$607K 0.03% 200
2023
Q2 		– Sell
-3,900
Closed -$873K – 315
2023
Q1 		$873K Buy
+3,900
New +$961K 0.06% 183

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Weiss Asset Management's UTHR Position: Q2 2026 in Review

Weiss Asset Management opened a new position in United Therapeutics (UTHR) in Q2 2026: 2,281 shares worth $1.24M. The stake represents 0.01% of the portfolio and ranks #399 among its holdings. This is a return to the name: Weiss Asset Management previously reported a position in UTHR as recently as Q4 2025.

Weiss Asset Management first reported a position in UTHR in Q1 2023 and has held it in 4 quarters since. The position peaked at $1.4M in Q4 2025. 884 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Weiss Asset Management held 2,281 shares of United Therapeutics worth $1.24M as of Q2 2026.
  • United Therapeutics was a new Weiss Asset Management position in Q2 2026.
  • United Therapeutics made up 0.01% of Weiss Asset Management's portfolio in Q2 2026, its #399 holding.
  • Weiss Asset Management first reported a position in United Therapeutics in Q1 2023 and has held it in 4 quarters since.
  • Weiss Asset Management's United Therapeutics position peaked at $1.4M in Q4 2025.
  • 884 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Weiss Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.